fda glp-1 warning letters news Beyond the Headlines: to Compounders US FDA sends 25 letters

PlexusDx Support for Your GLP-1 and Nutrition Plan PlexusDx compounded semaglutide injection is $189/mo month-to-month (or $149/mo on the 6-month plan) and serves all 50 states with no insurance requirement

Munib adjusts your protocol based on how you respond and your ongoing symptoms

It helps reduce cravings and makes dieting easier

In one study on children and adolescents, neurofeedback was as effective as methylphenidate in treating attention and hyperactivity symptoms

The FDA approved Wegovy for cardiovascular risk reduction in adults with established cardiovascular disease who are also overweight in March 2024, which opened the door for Medicare coverage in that specific population

For Novo and Lilly, its a tradeoff: lower prices for higher patient and prescription volume a bet that should pay off over time, especially since tariff relief is part of the deal